Home
Home » companies

Aeterna Zentaris

Æterna Zentaris Management Discusses Q1 2013 Results - Earnings Call Transcript

Æterna Zentaris Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha

This Week in Biotech

This Week in Biotech
Motley Fool

Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation

Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo

4 Small Biotechs With Big Clinical Trials Presenting In 2013

4 Small Biotechs With Big Clinical Trials Presenting In 2013
Seeking Alpha

Aeterna Zentaris soars on U.S. FDA trial agreement

Aeterna Zentaris soars on U.S. FDA trial agreement
Reuters

AEterna Zentaris And Progenics Pharmaceuticals - Rising From The Ashes In 2013?

AEterna Zentaris And Progenics Pharmaceuticals - Rising From The Ashes In 2013?
Seeking Alpha

The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013

The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool

Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013

Small Market Cap Pharmaceuticals With Large Catalysts Looming In 2013
Seeking Alpha

Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher

Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Seeking Alpha

A Dismal 2012 May Make For A Good Entry Now For AEterna Zentaris

A Dismal 2012 May Make For A Good Entry Now For AEterna Zentaris
Seeking Alpha